Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Inventory Average (2022 - 2025)

Axsome Therapeutics (AXSM) has disclosed Inventory Average for 4 consecutive years, with $25.9 million as the latest value for Q4 2025.

  • Quarterly Inventory Average rose 72.39% to $25.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.9 million through Dec 2025, up 72.39% year-over-year, with the annual reading at $21.8 million for FY2025, 41.48% up from the prior year.
  • Inventory Average hit $25.9 million in Q4 2025 for Axsome Therapeutics, up from $21.1 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $25.9 million in Q4 2025 to a low of $3.2 million in Q4 2022.
  • Historically, Inventory Average has averaged $13.4 million across 4 years, with a median of $14.9 million in 2024.
  • Biggest five-year swings in Inventory Average: surged 291.07% in 2023 and later increased 4.34% in 2025.
  • Year by year, Inventory Average stood at $3.2 million in 2022, then soared by 291.07% to $12.6 million in 2023, then rose by 19.41% to $15.0 million in 2024, then surged by 72.39% to $25.9 million in 2025.
  • Business Quant data shows Inventory Average for AXSM at $25.9 million in Q4 2025, $21.1 million in Q3 2025, and $17.4 million in Q2 2025.